Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-arm Phase II Clinical Study of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for Clinical T3N+ Locally Advanced Esophageal Cancer

NCT06965829 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT06965829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-arm Phase II Clinical Study of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for Clinical T3N+ Locally Advanced Esophageal Cancer
Lead sponsor
Shanghai Chest Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer stage iii